Antimicrobial Resistance and Antimicrobial Therapy of Clinically Relevant Bacteria

Antimicrobial resistance is a public health problem of major importance, and the World Health Organization (WHO) has warned that the current antibiotic armamentarium is not sufficient to face future challenges. The antibiotic pipeline is not providing new compounds at a sufficient speed for various...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Fformat: Online
Iaith:Saesneg
Cyhoeddwyd: MDPI - Multidisciplinary Digital Publishing Institute 2026
Pynciau:
Mynediad Ar-lein:https://library.oapen.org/handle/20.500.12657/110077
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
_version_ 1869520680376074240
collection Directory of Open Access Books
description Antimicrobial resistance is a public health problem of major importance, and the World Health Organization (WHO) has warned that the current antibiotic armamentarium is not sufficient to face future challenges. The antibiotic pipeline is not providing new compounds at a sufficient speed for various reasons, and thus, few novel drugs have reached clinical practice lately; old, formerly abandoned antimicrobials are increasingly used as last-resort treatment options. At this pace, untreatable infections could emerge on a large scale, and the world may experience, in some cases, dramatic situations of the pre-antibiotic era. Already, clinicians in endemic areas routinely encounter patients with infections that do not respond to available treatments, and laboratories often report multidrug-resistant (MDR) or even pan-drug-resistant (PDR) bacteria. In this context, continuous monitoring of the resistance mechanisms’ epidemiology, as well as knowledge regarding treatment options for clinically relevant bacteria, are of great interest to health-care professionals. This Reprint includes articles that present new data on antimicrobial resistance and epidemiology of MDR bacterial infections of key clinical importance, as well as suitable therapeutic options for their treatment. Hopefully, these contributions will both practically benefit the readership and stimulate further research in the field.
format Online
id doab-20.500.12854ir-172248
institution Directory of Open Access Books
language eng
publishDate 2026
publishDateRange 2026
publishDateSort 2026
publisher MDPI - Multidisciplinary Digital Publishing Institute
publisherStr MDPI - Multidisciplinary Digital Publishing Institute
record_format ojs
spelling doab-20.500.12854ir-1722482026-02-26T05:17:30Z Antimicrobial Resistance and Antimicrobial Therapy of Clinically Relevant Bacteria Meletis, Georgios Skoura, Lemonia Protonotariou, Efthymia Antimicrobial resistance mechanisms Antimicrobial resistance detection Antimicrobial resistance epidemiology Antimicrobial treatment New antibiotics MDR Klebsiella pneumoniae Acinetobacter baumannii Pseudomonas aeruginosa MRSA thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacology Antimicrobial resistance is a public health problem of major importance, and the World Health Organization (WHO) has warned that the current antibiotic armamentarium is not sufficient to face future challenges. The antibiotic pipeline is not providing new compounds at a sufficient speed for various reasons, and thus, few novel drugs have reached clinical practice lately; old, formerly abandoned antimicrobials are increasingly used as last-resort treatment options. At this pace, untreatable infections could emerge on a large scale, and the world may experience, in some cases, dramatic situations of the pre-antibiotic era. Already, clinicians in endemic areas routinely encounter patients with infections that do not respond to available treatments, and laboratories often report multidrug-resistant (MDR) or even pan-drug-resistant (PDR) bacteria. In this context, continuous monitoring of the resistance mechanisms’ epidemiology, as well as knowledge regarding treatment options for clinically relevant bacteria, are of great interest to health-care professionals. This Reprint includes articles that present new data on antimicrobial resistance and epidemiology of MDR bacterial infections of key clinical importance, as well as suitable therapeutic options for their treatment. Hopefully, these contributions will both practically benefit the readership and stimulate further research in the field. 2026-02-25T05:13:57Z 2026-02-25T05:13:57Z 2026-02-24T07:24:02Z 2025 book https://library.oapen.org/handle/20.500.12657/110077 9783725860777 https://directory.doabooks.org/handle/20.500.12854/172248 eng open access image/jpeg Attribution-NonCommercial-NoDerivatives 4.0 International https://library.oapen.org/bitstream/20.500.12657/110077/1/9783725860777.pdf MDPI - Multidisciplinary Digital Publishing Institute 10.3390/books978-3-7258-6078-4 10.3390/books978-3-7258-6078-4 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 9783725860777 114 Basel, Switzerland open access
spellingShingle Antimicrobial resistance mechanisms
Antimicrobial resistance detection
Antimicrobial resistance epidemiology
Antimicrobial treatment
New antibiotics
MDR
Klebsiella pneumoniae
Acinetobacter baumannii
Pseudomonas aeruginosa
MRSA
thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacology
Antimicrobial Resistance and Antimicrobial Therapy of Clinically Relevant Bacteria
title Antimicrobial Resistance and Antimicrobial Therapy of Clinically Relevant Bacteria
title_full Antimicrobial Resistance and Antimicrobial Therapy of Clinically Relevant Bacteria
title_fullStr Antimicrobial Resistance and Antimicrobial Therapy of Clinically Relevant Bacteria
title_full_unstemmed Antimicrobial Resistance and Antimicrobial Therapy of Clinically Relevant Bacteria
title_short Antimicrobial Resistance and Antimicrobial Therapy of Clinically Relevant Bacteria
title_sort antimicrobial resistance and antimicrobial therapy of clinically relevant bacteria
topic Antimicrobial resistance mechanisms
Antimicrobial resistance detection
Antimicrobial resistance epidemiology
Antimicrobial treatment
New antibiotics
MDR
Klebsiella pneumoniae
Acinetobacter baumannii
Pseudomonas aeruginosa
MRSA
thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacology
topic_facet Antimicrobial resistance mechanisms
Antimicrobial resistance detection
Antimicrobial resistance epidemiology
Antimicrobial treatment
New antibiotics
MDR
Klebsiella pneumoniae
Acinetobacter baumannii
Pseudomonas aeruginosa
MRSA
thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacology
url https://library.oapen.org/handle/20.500.12657/110077